News about Global Pharma

Veravas Launches VeraBIND Tau, First Blood Test to Aid Alzheimer's Detection

The first-in-class assay is available now as a laboratory-developed test (LDT) through Veravas. It was validated and is performed in a CLIA / CAP certified lab.

Global Pharma | 23/04/2025 | By Manvi |  287

Epiminder's Minder EEG Implant Wins FDA De Novo, Breakthrough Status for Epilepsy

Epiminder announced that it has been granted FDA authorisation via the De Novo classification for Minder, its proprietary implantable continuous electroencephalogram monitoring system (iCEMTM) for patients with epilepsy.

Global Pharma | 23/04/2025 | By Manvi |  461

Eugia Pharma Secures USFDA Approval for Dasatinib Tablets

Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received final USFDA approval to manufacture and market Dasatinib Tablets in varying dosages for the treatment of certain types of leukemia. The product is expected to be launched in Q1 FY26.

Global Pharma | 23/04/2025 | By Manvi |  781

Caplin Steriles Secures USFDA Approval for Phytonadione Injectable Emulsion

Caplin Steriles Ltd., a subsidiary of Caplin Point Laboratories, has received final USFDA approval for its generic Phytonadione Injectable Emulsion USP (10 mg/mL), a therapeutic equivalent to Hospira's Vitamin K1 Injection.

Global Pharma | 23/04/2025 | By Manvi |  800

Suanfarma Appoints Mane Godina as its New CEO

Suanfarma has appointed Pere Mañé Godina as its new CEO, ushering in a new phase focused on industrial consolidation, sustainable innovation, and global expansion.

Global Pharma | 22/04/2025 | By Manvi |  200

Jazz Pharmaceuticals Acquires Chimerix for USD 935 Million

Jazz Pharmaceuticals plc has completed its USD 935 million acquisition of Chimerix, Inc., making it a wholly owned subsidiary and strengthening its oncology portfolio with the addition of the novel drug candidate Dordaviprone.

Global Pharma | 22/04/2025 | By Manvi |  214

BD Launches AI-Powered Hemodynamic Monitoring Platform to Enhance Patient Safety During Procedures

BD (Becton, Dickinson and Company) has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.

Global Pharma | 22/04/2025 | By Manvi |  211

ARUP Laboratories Introduces pTau 217 Blood Test to Support Alzheimer's Disease Diagnosis in Older Adults

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.

Global Pharma | 22/04/2025 | By Manvi |  453

Sanoculis Receives CE Mark Approval for MINT Glaucoma Surgery Device in EU

Sanoculis Ltd. announced that it has received CE Mark approval under the Medical Device Regulation (MDR) in the European Union (EU) for its MINT® (Minimally Invasive Nasal Trabeculostomy) product—an innovative, stent-free technology platform for the treatment of adult patients undergoing glaucoma angle surgery.

Global Pharma | 21/04/2025 | By Manvi |  267

FDA Classifies Q'Apel Medical's Recall of 072 Aspiration System as Class I

US Food and Drug Administration, classified Q'Apel Medical, Inc.'s voluntary recall of 1,617 units of its 072 Aspiration System (also known under the product name 'Hippo', which includes 'Cheetah'; collectively, the 'product') as Class I.

Global Pharma | 21/04/2025 | By Manvi |  221